Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Aldehyde doai
Patent
1993-05-20
1995-04-11
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Aldehyde doai
514689, 514691, A61K 3135
Patent
active
054058759
ABSTRACT:
The present invention provides a method of inhibiting neoplasia and tumor promotion. The method comprises administering to a mammal, particularly a human, in need thereof an effective amount of a 12-deoxyphorbol ester, particularly a 12-deoxyphorbol 13-monoester such as 12-deoxyphorbol 13-acetate (prostratin) and 12-deoxyphorbol 13-phenylacetate (dPP).
REFERENCES:
patent: 4716179 (1987-12-01), Hecker et al.
patent: 5021450 (1991-06-01), Blumberg
Aftab et al., "Structure-Activity Relationships of Phenothiazines and Related Drugs for Inhibition of Protein Kinase C," Molecular Pharmacology, 40, 798-805 (1991).
Akita et al., "Expression and Properties of Two Distinct Classes of the Phorbol Ester Receptor Family, Four Conventional Protein Kinase C Types, and a Novel Protein Kinase C," J. Biological Chemistry, 265(1) 354-362 (Jan. 1990).
Baird et al., "Tumor-promoting Activity of Phorbol and Four Diesters of Phorbol in Mouse Skin," Cancer Research, 31, 1074-79 (Aug. 1971).
Berry et al., "Metabolic Conversion of 12-O-Tetradecanoylphorbol-13-acetate in Adult and Newborn Mouse Skin and Mouse Liver Microsomes," Cancer Research, 38, 2301-06 (Aug. 1978).
Binder et al., "Characterization of the Induction of Ornithine Decarboxylase Activity by Benzoyl Peroxide in SENCAR Mouse Epidermis," Carcinogenesis, 10(12), 2351-57 (1989).
Blumberg et al., "Specific Receptors for Phorbol Ester Tumor Promoters and Their Involvement in Biological Responses" (Chapter 5) in Mechanisms of Tumor Promotion (vol. III) (Thomas J. Slaga, ed., CRC Press, Inc., Boca Raton, Fla. 1984).
Blumberg, "Protein Kinase C as the Receptor for the Phorbol Ester Tumor Promoters: Sixth Rhoads Memorial Award Lecture" Cancer Research, 48, 1-8 (Jan. 1988).
Blumberg, "Complexities of the Protein Kinase C Pathway," Mol. Carcinog., 4, 339-344 (1991).
Blumberg et al., "The Bryostatins, A Family of Protein Kinase C Activators with Therapeutic Potential" in New Leads and Targets in Drug Research, 273-285 (Krogsgaard-Larsen et al., eds., Alfred Benzon Symposium 33, Munksgaard, Copenhagen 1992).
Campbell, "Lipid-Derived Autacoids: Eicosanoids and Platelet-Activating Factor" (Chapter 24) in Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th Ed. (Gilman et al., ed., Pergamon Press, New York 1990).
Cashmore et al., "The Structure of Prostratin: A Toxic Tetracyclic Diterpene Ester from Pimelea Prostrata," Tetrahedron Lett., 1737-1738 (1976).
Casnellie, "Protein Kinase Inhibitors: Probees for the Functions of Protein Phosphorylation," Advances in Pharmacology, 22, 167-71 (1991).
DiGiovanni et al., "Structure-Activity Relationships for Epidermal Ornithine Decarboxylase Induction and Skin Tumor Promotion by Anthrones," Carcinogenesis, 9(8), 1437-43 (1988).
Driedger et al., "Structure-Activity Relationships in Chick Embryo Fibroblasts for Phorbol-related Diterpene Esters Showing Anomalous Activities in Vivo," Cancer Res., 40, 339-346 (1980).
Dunn et al., "Specific Binding of [20-.sup.3 H]12-Deoxyphorbol 13-Isobutyrate to Phorbol Ester Receptor Subclasses in Mouse Skin Particulate Preparations," Cancer Research, 43, 4632-37 (Oct. 1983).
Ellis et al., "Activation of Protein Kinase C by Tumor-Promoting and Non-Promoting Phorbol Esters," J. Pharmacy and Pharmacology,37, 23P (Dec. 1985).
Fischer et al., "Correlation of Phorbol Ester Promotion in the Resistant C57BL/6J Mouse with Sustained Hyperplasia But Not Ornithine Decarboxylase or Protein Kinase C," Cancer Res., 49, 6693-6699 (1989).
Furstenberger et al., "Skin Tumor Promotion by Phorbol Esters Is A Two-Stage Process," Proc. Natl. Acad. Sci. USA, 78(12), 7722-26 (Dec. 1981).
Goth, "Drug-Receptor Interactions" (Chapter 2) in Medical Pharmacology Principles and Concepts, 10th Ed. (The C.V. Mosby Company, St. Louis 1981).
Gschwendt et al., "Bryostatin 1, An Activator of Protein Kinase C, Mimics As Well As Inhibits Biological Effects of the Phorbol Ester TPA in vivo and in vitro," Carcinogenesis, 9(4), 555-62 (1988).
Gustafson et al., "A Nonpromoting Phorbol from the Samoan Medicinal Plant Homalanthus nutans Inhibits Cell Killing by HIV-1," J. Med. Chem., 35, 1978-1986 (1992).
Hecker, "Cocarciogens from Euphorbiaceae and Thymeleaceae" in Symposium on Pharmacognosy and Phytochemistry, 147-165 (Wagner et al., eds., Springer Verlag 1970).
Hecker, "Structure-Activity Relationships in Diterpene Esters Irritant and Cocarcinogenic to Mouse Skin" in Carcinogenesis, vol. 2. Mechanisms of Tumor-Promotion and Carcinogenesis, 11-47 (Slaga et al., eds., Raven Press, New York 1978).
Hegemann et al., "The Antipsoriatic Drug, Anthralin, Inhibits Protein Kinase C--Implications for Its Mechanism of Action," Arch. Dermatol. Res., 284, 179-183 1992).
Hennings et al., "Bryostatin 1, An Activator of Protein Kinase C, Inhibits Tumor Promotion by Phorbol Esters in SENCAR Mouse Skin," Carcinogenesis, 8(9), 1343-46 (1987).
Hergenhahn et al., "Biological Assays for Irritant Tumor-initiating and -promoting Activities," J. Cancer Res. Clin. Oncol., 104, 31-39 (1982).
Insel, "Angalgesic.varies.Antipyretics and Antiinflammatory Agents; Drugs Employed in the Treatment of Rheumatoid Arthritis and Gout" (Chapter 26) in Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th Ed. (Gilman et al., ed., Pergamon Press, New York 1990).
Irie et al., "Structure--Activity Studies of the Indole Alkaloid Tumor Promoter Teleocidins," Carcinogenesis, 8(4), 547-552 (1987).
Kazanietz eta l., "Differential Irreversible Insertion of Protein Kinase C into Phospholipid Vesicles by Phorbol Esters and Related Activators," J. Biol. Chem., 267(29), 20878-20886 (1992).
Klein-Szanto, "Morphological Evaluation of Tumor Promoter Effects on Mammalian Skin" (Chapter 3) in Mechanism of Tumor Promotion (vol. II) (Thomas J. Slaga, ed., CRC Press, Inc., Boca Raton, Fla. 1984).
Lichti et al., "Genetic Evidence That a Phorbol Ester Tumor Promoter Stimulates Ornithine Decarboxylase Activity by a Pathway That Is Independent of Cyclic AMP-Dependent Protein Kinases in CHO Cells," J. Cellular Physiology, 113, 433-39 (1982).
Madri, "Inflammation and Healing" (Chapter 2) in Anderson's Pathology, 9th Ed. (Kissane, ed., The C.V. Mosby Company, St. Louis 1990).
Nishizuka, "The Role of Protein Kinase C in Cell Surface Signal Transduction and Tumour Promotion," Nature, 308(19), 693-98 (Apr. 1984).
Nishizuka, "Studies and Perspectives of Protein Kinase C," Science, 233, 305-12 (Jul. 1986).
Nishizuka, "The Molecular Heterogeneity of Protein Kinase C and Its Implications for Cellular Regulation," Nature, 334(25), 661-65 (Aug. 1988).
Nishizuka, "Studies and Prospectives of the Protein Kinase C Family for Cellular Regulation," Cancer, 63, 1892-1903 (May 1989).
Nishizuka, "Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C," Science, 258, 607-614 (1992).
O'Brien et al., "Induction of the Polyamine-biosynthetic Enzymes in Mouse Epidermis by Tumor-promoting Agents," Cancer Research, 35, 1662-70 (Jul. 1975).
Sako et al., "Partial Parallelism and Partial Blockade by Bryostatin 1 of Effects of Phorbol Ester Tumor Promoters on Primary Mouse Epidermal Cells," Cancer Research, 47, 5445-50 (Oct. 1987).
Schmidt et al., "Simple Phorbol Esters as Inhibitors of Tumor Promotion by TPA in Mouse Skin," in Carcinogenesis and Biological Effects of Tumor Promoters, 7, 57-63 (Hecker et al., eds., Raven Press, New York 1982).
Scribner et al., "Inflammation and Tumor Promotion: Selective Protein Induction in Mouse Skin by Tumor Promoters," Europ. J. Cancer, 8, 617-621 (1972).
Sekiguchi et al., "Three Distinct Forms of Rat Brain Protein Kinase C: Differential Response to Unsaturated Fatty Acids," Biochemical and Biophysical Research Communications, 145(2), 797-802 (Jun. 1987).
Sisskin et al., "Correlation Between Sensitivity to Tumor Promotion and Sustained Epidermal Hyperplasia of Mice and Rats Treated with 12-O-tetradecanoylphorbol-13-acetate," Carcinogenesis, 3(4), 403-407 (1982).
Slaga et al., "Studies on the Mechanism of Skin Tumor Promotion: Evidence for Several Stages in Promotion," Proc. Natl. Acad. Sci. USA, 77(6), 3659-3663 (Jun. 19
Blumberg Peter M.
Szallasi Zoltan
Peabody John
Richter Johann
The United States of America as represented by the Department of
LandOfFree
Method of inhibiting neoplasia and tumor promotion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting neoplasia and tumor promotion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting neoplasia and tumor promotion will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1538830